Sturniolo GC, Mestriner C, Lecis PE, et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis.
Scand J Gastroenterol. 1998;33:644-649.
Mortensen PB, Abildgaard K, Fallingborg J. Serum selenium concentration in patients with ulcerative colitis.
Dan Med Bull. 1989;36:568-570.
Dronfield MW, Malone JD, Langman MJ. Zinc in ulcerative colitis: a therapeutic trial and report on plasma levels.
Elsborg L, Larsen L. Folate deficiency in chronic inflammatory bowel disease.
Scand J Gastroenterol.1979;14:1019-1024.
Krasinski SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders.
Am J Clin Nutr. 1985;41:639-643.
Bischoff SC, Herrmann A, Goke M, et al. Altered bone metabolism in inflammatory bowel disease.
Am J Gastroenterol. 1997;92:1157-1163.
Dibble JB, Sheridan P, Losowsky MS. A survey of vitamin D deficiency in gastrointestinal and liver disorders.
Q J Med. 1984;53:119-134.
Mulder TP, van der Sluys Veer A, Verspaget HW, et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease.
J Gastroenterol Hepatol. 1994;9:472-477.
Harries AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn's disease: association with nutrition and disease activity.
Harries AD, Jones LA, Danis V, et al. Controlled trial of supplemented oral nutrition in Crohn's disease.
Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.
N Engl J Med. 1996;334:1557-1560.
Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).
Scand J Gastroenterol.
Van Den Bogaerde J, Cahill J, Emmanuel AV, et al. Gut mucosal response to food antigens in Crohn's disease.
Aliment Pharmacol Ther. 2002;16:1903-1915.
Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.
J Pediatr Gastroenterol Nutr. 2000;30:78-84.
Den Hond E, Hiele M, Peeters M, et al. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease.
JPEN J Parenter Enteral Nutr. 1999;23:7-11.
van der Hulst, RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity.
Plein K, Hotz J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea—a pilot study.
Z Gastroenterol. 1993;31:129-134.
Knoflach P, Park BH, Cunningham R, et al. Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease.
Pearson M, Teahon K, Levi AJ, et al. Food intolerance and Crohn's disease.
Gerhardt H, Seifert F, Buvari P, Vogelsang H, et al. Therapy of active Crohn disease with Boswellia serrata extract H 15.
Romano C, Cucchiara S, Barabino A et al. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study.
World J Gastroenterol.
Bousvaros A, Guandalini S, Baldassano RN et al. A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease.
Inflamm Bowel Dis.
Marteau P, Lemann M, Seksik P et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial.
2005 Dec 23 [Epub ahead of print].
Karimi O, Pena AS, van Bodegraven AA et al. Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: A pilot study.
Drugs Today (Barc).
Joos S, Brinkhaus B, Maluche C et al. Acupuncture and Moxibustion in the Treatment of Active Crohn's Disease: A Randomized Controlled Study.
Digestion. 2004 Apr 26 [Epub ahead of print].
Van Gossum A, Dewit O, Louis E, et al. Multicenter randomized-controlled clinical trial of probiotics (
Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection.
Inflamm Bowel Dis. 2006 Dec 19 [Epub ahead of print].
Omer B, Krebs S, Omer H, et. al. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: A double-blind placebo-controlled study.
Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease.
Dig Dis Sci.
2008 Feb 14.
Feagan BG, Sandborn WJ, Mittmann U, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.
Hou JK, Abraham B, El-Serag H.
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.
Am J Gastroenterol.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.